Apr 15, 2021
Johnson & Johnson: Continue to believe in positive benefit-risk profile of COVID-19 vaccine
“We continue to believe in a positive benefit-risk profile of COVID-19 vaccine,” Johnson & Johnson said in response to the statement released after th
Mehr darüber lesen
Previous